NDVR »

Halozyme Therapeutics shares owned by NDVR

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by NDVR from 13F filings

Historical chart of NDVR investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by NDVR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by NDVR

Quarter filed Position value Share count Share price at filing
2025-12-31 $240k 3.6k 67.30

More positions owned by NDVR

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Hubspot (HUBS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
World Gold Tr Spdr Gld Minis (GLDM)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for NDVR

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Norges Bank Investment Management
William Blair Investment Management
Alliancebernstein
D. E. Shaw & Co
Federated Investors
Jupiter Asset Management
Millennium Management

View all funds holding Halozyme Therapeutics